Equitable Holdings, Inc. Gilead Sciences, Inc. Transaction History

Equitable Holdings, Inc.

$9.13 Billion
Q2 2024

A detailed history of Equitable Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Equitable Holdings, Inc. holds 63,907 shares of GILD stock, worth $5.86 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

63,907

Previous 62,480 2.28%

Holding current value

$5.86 Million

Previous $4.58 Million 4.2%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $90,115 - $103,999	1,427 Added 2.28%	63,907 $4.38 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $28,989 - $35,352	405 Added 0.65%	62,480 $4.58 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $37,953 - $43,040	518 Added 0.84%	62,075 $5.03 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $154,534 - $168,600	2,090 Added 3.51%	61,557 $4.61 Million
Q2 2023 Aug 15, 2023	BUY	$76.01 - $86.7 $305,864 - $348,880	4,024 Added 7.26%	59,467 $4.58 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $514,575 - $586,260	6,656 Added 13.64%	55,443 $4.6 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $47,550 - $68,265	763 Added 1.59%	48,787 $4.19 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $12,146 - $13,874	-204 Reduced 0.42%	48,024 $2.96 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $30,014 - $33,805	520 Added 1.09%	48,228 $2.98 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $397,562 - $498,189	6,864 Added 16.81%	47,708 $2.84 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $26,535 - $30,118	-409 Reduced 0.99%	40,844 $2.97 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $10,559 - $11,392	156 Added 0.38%	41,253 $2.88 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $38,018 - $41,540	599 Added 1.48%	41,097 $2.83 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $347,820 - $396,862	5,797 Added 16.71%	40,498 $2.62 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $56,819 - $64,743	-1,003 Reduced 2.81%	34,701 $2.02 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $95,323 - $119,852	1,535 Added 4.49%	35,704 $2.26 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $82,539 - $95,844	-1,141 Reduced 3.23%	34,169 $2.63 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $121,502 - $155,626	1,940 Added 5.81%	35,310 $2.64 Million
Q4 2019 Feb 18, 2020	BUY	$61.62 - $67.78 $2.06 Million - $2.26 Million	33,370 New	33,370 $2.17 Million

Others Institutions Holding GILD

# of Institutions

1,908

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.03M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.

Account

Equitable Holdings, Inc. Gilead Sciences, Inc. Transaction History